Physician profile
Robert Winfred West
NPI 1467555276
$2,476.44
in general payments reported to CMS, 2019-2025
19 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $520 · 2020: $147 · 2021: $519 · 2022: $460 · 2023: $305 · 2024: $343 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $904.59 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $592.88 | 2021-2024 | Vraylar, Ubrelvy, Qulipta |
| Abbott Laboratories | $196.44 | 2021-2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $156.00 | 2019-2021 | |
| Dexcom, INC. | $140.07 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $80.30 | 2019-2024 | |
| Astellas Pharma US INC | $76.36 | 2019-2023 | Veozah |
| Allergan, INC. | $60.06 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $57.30 | 2019 | |
| Glaxosmithkline, LLC. | $50.98 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $26.84 | 2019-2020 | |
| Lundbeck LLC | $25.28 | 2023 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $23.74 | 2019-2021 | |
| Philips North America LLC | $16.64 | 2019 | |
| Idorsia Pharmaceuticals US INC | $14.97 | 2023 | Quviviq |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $14.07 | 2024 | Cologuard Collection Kit |
| Medtronic Minimed, INC. | $14.03 | 2019 | |
| Amgen INC. | $13.89 | 2025 | Evenity, Prolia |
| Teva Pharmaceuticals USA, INC. | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.